Treatment of Tourette Syndrome with Cannabinoids
Cannabinoids have been used for hundred of years for medical purposes. To day, the cannabinoid delta-9-tetrahydrocannabinol (THC) and the cannabis extract nabiximols are approved for the treatment of nausea, anorexia and spasticity, respectively. In Tourette syndrome (TS) several anecdotal reports p...
Main Author: | Kirsten R. Müller-Vahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.3233/BEN-120276 |
Similar Items
-
Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols
by: Ahmad Seif Kanaan, et al.
Published: (2017-04-01) -
Editorial: The Neurobiology and Genetics of Gilles de la Tourette Syndrome: New Avenues through Large-Scale Collaborative Projects
by: Peristera Paschou, et al.
Published: (2017-10-01) -
Cognitive flexibility and its electrophysiological correlates in Gilles de la Tourette syndrome
by: Florian Lange, et al.
Published: (2017-10-01) -
Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients
by: Ewgeni Jakubovski, et al.
Published: (2017-08-01) -
Challenges in the Diagnosis and Assessment in Patients with Tourette Syndrome and Comorbid Obsessive-Compulsive Disorder
by: Szejko N, et al.
Published: (2021-04-01)